Placebo to match LY3556050 clinical trials

J2P-MC-LXBD: A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to Evaluate LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

This study is testing a new medicine, LY3556050, for adults who have pain from diabetes nerve damage. It's a key step to see if the medicine can help reduce pain, compared to a dummy pill, to find the best dose.